# Postoperative Tolvaptan Use in Left Ventricular Assist Device Implantation Patients

> **NCT05408104** · — · COMPLETED · sponsor: **University of Chicago** · enrollment: 28 (actual)

## Conditions studied

- Heart Failure
- Heart Assist Device
- Hyponatremic

## Interventions

- **DRUG:** tolvaptan

## Key facts

- **NCT ID:** NCT05408104
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-28
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-05-01
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2022-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05408104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05408104, "Postoperative Tolvaptan Use in Left Ventricular Assist Device Implantation Patients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05408104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*